• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Neuroscience

The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next
  • expand A Double-blind, Randomized, 2-Period Crossover Study to Compare the Safety and Tolerability of a Titration of Sustained Release Formulation Quetiapine Fumarate (SEROQUEL) with Placebo in Healthy Volunteers
    Study Id
    D1448C00013
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1448C00013
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Double blind, Randomized, 2-Period Crossover Study to Compare the Tolerance and Safety of Sustained Release Formulation Quetiapine Fumarate (SEROQUEL) with Placebo in Healthy Volunteers
    Study Id
    D1448C00008
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1448C00008
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A 6-week, Double-blind, Randomized, Parallel-group, International, Multi-center, Phase III Study Comparing the Efficacy and Safety of Sustained-Release and Immediate-Release Quetiapine Fumarate (SEROQUEL) to PLacebo in the Treatment of Agitation Associated with Alzheimer's Dementia in Elderly Residents of Long-term Care Facilities.
    Study Id
    D1444C00148
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1444C00148
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Phase I, Randomized, Double-Blind, Parallel Group, Multi-Center Study to Compare the Safety and Tolerability of Two Titration Schemes for Sustained-Release Quetiapine Fumarate with a Constant-Dose Scheme of Sustained-Release Quetiapine Fumarate in Schizophrenic and Schizoaffective Patients
    Study Id
    D1444C00145
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1444C00145
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand A Study to Compare the Pharmacokinetics of 50 mg and 300 mg Quetiapine fumarate SR Tablets Administered following a Light Meal and in the Fasted State in Adult Volunteers and Adults with Schizophrenia, Schizoaffective Disorder or Bipolar Disorder
    Study Id
    D1444C00003
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1444C00003
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Phase I Randomized, Open Label 5- Treatment Study
    Study Id
    D1444C00001
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1444C00001
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Quetiapine bioequivalence study_Austria_Local
    Study Id
    D1443L00077
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1443L00077
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Driving ability under Quetiapine
    Study Id
    D1443L00041
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1443L00041
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand UK SMS Study
    Study Id
    D1443L00024
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1443L00024
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • expand Efficacy &amp Safety in Rapid Titration Manic Bipolar Disorder
    Study Id
    D1443C00004
    Disease
    schizophrenia
    Drug Name
    Seroquel
    Study Name
    D1443C00004
    Recruiting Status
    Closed
    Protocol Status
    Not Available
    Report Status
    Not Available
  • Pages
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013